Search

everythinglearnresearchcommunity

for

Search:↓

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Managing inflammation and using vitamins can improve PRP therapy for better hair growth.

ILC1-like cells can independently cause alopecia areata.

PPARγ is essential for maintaining healthy skin, controlling inflammation, and ensuring proper skin barrier function.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Targeting Vδ1+T-cells may help treat alopecia areata.

Skin diseases like acne and psoriasis are linked to stress, gut health, and inflammation, with new treatments focusing on gut and mind-body approaches.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

Paris polyphylla saponins may effectively treat acne due to their antibacterial and anti-inflammatory properties.

Microneedling may improve quality of life and reduce inflammation in frontal fibrosing alopecia.

Pine bark extract helps mice grow hair by reducing inflammation and boosting growth factors.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Some horses lose hair without inflammation or itching due to various conditions, and while mainly a cosmetic issue, diagnosis requires examination and biopsies, and breeding is not advised if it's hereditary.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Hair transplants can rarely cause scalp inflammation leading to hair loss, needing early detection and treatment.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Erosive pustular dermatosis of the scalp is a type of skin inflammation often confused with other conditions, requiring continuous treatment.

The new hydrogel treatment promotes faster hair growth and better skin health for hair loss.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

Increased blood vessel growth in lichen planopilaris may signal active disease needing aggressive treatment.

A new microneedle patch effectively and safely treats alopecia areata.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.